Guido Baselli

6PUBLICATIONS
44CO-AUTHORS
Immunogenetics (incl. genetic immunology)Women's studies (incl. girls' studies)Gene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)Neurogenetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 09, 2024
Predicting inhibitor development using a random peptide phage-display library approach in the SIPPET cohort.

Shermarke Hassan, Guido Baselli, Luca Mollica

|Sep 25, 2023
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women.

Alessandro Cherubini, Mahnoosh Ostadreza, Oveis Jamialahmadi

|Mar 23, 2022
Hepatic IRF3 fuels dysglycemia in obesity through direct regulation of Ppp2r1b.

Suraj J Patel, Nan Liu, Sam Piaker

|Feb 01, 2022
PSD3 downregulation confers protection against fatty liver disease.

Rosellina M Mancina, Kavitha Sasidharan, Anna Lindblom

|Mar 08, 2019
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.

Serena Pelusi, Guido Baselli, Alessandro Pietrelli

Pageof 1